Search results
Should You Buy This Stock After a Regulatory Setback?
The Motley Fool via AOL· 2 hours agoThough the biotech was highly successful in the COVID-19 vaccine market, investors rightly expecting...
Misleading Claims on Well-Known Rare Risk of AstraZeneca COVID-19 Vaccine - FactCheck.org
FactCheck.org· 3 days agoA rare risk of dangerous blood clots associated with the AstraZeneca COVID-19 vaccine was identified and reported in early 2021. This month, the company ...
The growing promise of cancer vaccines
Cosmos· 10 hours agoA cure for cancer — which is second only to cardiovascular diseases in its contribution to the global burden of disease — has long been a dream. While no magic bullet is yet in sight, three ...
Here's how U.S. health officials are responding to bird flu in humans after second case
CNBC· 2 days agoU.S. health officials are monitoring and preparing to combat bird flu in humans, even as they...
Sarasota hospital board bucks Ladapo's claims against COVID-19 vaccines
WUSF 89.7· 4 days agoSarasota Memorial Health Care System will not endorse Florida Surgeon General Joseph Ladapo's guidance against COVID-19 vaccines on its website, as one ...
Sarasota hospital board sidesteps proposal to endorse Ladapo anti-vaccine stance
Herald-Tribune via Yahoo News· 4 days ago“To ask any of us to do otherwise – to deviate from scientifically approved treatment is a pill that...
3 Reliable Dividend Stocks With Yields Above 5% You Can Buy With Less Than $100 Right Now
Motley Fool via Yahoo Finance· 6 days agoPfizer's revenue stream swelled up on sales of Comirnaty, a COVID-19 vaccine, and Paxlovid, a COVID...
The truth behind new weight loss drugs
KARE 11 Minneapolis-St. Paul· 3 days agoYou’ve probably heard about those popular drugs being used for weight loss. Originally, they were made to fight diabetes, then they were prescribed for...
Harnessing RNAi: Alnylam’s Path From Lab Discovery to Life-Changing Treatments
SciTechDaily· 3 days agoAlnylam Pharmaceuticals, founded by MIT professors and former postdocs, has developed five FDA-...
AstraZeneca targets $80 billion in total revenue by 2030 in 'post-Covid era'
CNBC· 5 days agoThe Astrazeneca logo is pictured at the World Artificial Intelligence Conference 2021 in Shanghai,...
